The role of hyperglycaemia and the hypercoagulable state in the pathogenesis of cardiovascular events in diabetes mellitus: Implications for hypertension management

被引:9
作者
Lim, Hoong Sern [1 ]
MacFadyen, Robert J. [1 ]
Bakris, George [1 ]
Lip, Gregory Y. H. [1 ]
机构
[1] Univ Birmingham Hosp, Dept Med, Haemostasis Thrombosis & Vasc Biol Unit, Birmingham B18 7QH, W Midlands, England
关键词
diabetes; endothelium; glucose; insulin resistance; thrombosis;
D O I
10.2174/138161206776843322
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Population studies have identified diabetes mellitus as a risk factor for cardiac and vascular events, with a common association with hypertension. Observational studies have consistently demonstrated blood glucose as a continuous cardiovascular risk factor. Experimental studies suggest that elevated blood glucose, through a range of biochemical pathways can promote atherogenesis and increase the tendency for thrombosis. The resultant state promotes occlusion of arterial flow and increase cardiovascular event rates. However, an unconvincing temporal relationship (raised blood glucose preceding cardiovascular events) and the limited impact of glucose reduction in patients with diabetes on cardiovascular events do not support blood glucose as a major cause of cardiovascular disease. In this review, we discuss the relationship between hyperglycaemia and a hypercoagulable state in diabetes and the implications of this relationship for the treatment of patients with diabetes, who also commonly have hypertension.
引用
收藏
页码:1567 / 1579
页数:13
相关论文
共 143 条
[61]   NIDDM is associated with lower wall shear stress of the common carotid artery [J].
Irace, C ;
Carallo, C ;
Crescenzo, A ;
Motti, C ;
De Franceschi, MS ;
Mattioli, PL ;
Gnasso, A .
DIABETES, 1999, 48 (01) :193-197
[62]   von Willebrand factor, C-reactive protein, and 5-year mortality in diabetic and nondiabetic subjects - The Hoorn study [J].
Jager, A ;
van Hinsbergh, VWM ;
Kostense, PJ ;
Emeis, JJ ;
Yudkin, JS ;
Nijpels, G ;
Dekker, JM ;
Heine, RJ ;
Bouter, LM ;
Stehouwer, CDA .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (12) :3071-3078
[63]   von Willebrand factor, tissue plasminogen activator, and dehydroepiandrosterone sulphate predict cardiovascular death in a 10 year follow up of survivors of acute myocardial infarction [J].
Jansson, JH ;
Nilsson, TK ;
Johnson, O .
HEART, 1998, 80 (04) :334-337
[64]   TYPE-2 (NON-INSULIN-DEPENDENT) DIABETES-MELLITUS AND CARDIOVASCULAR-DISEASE - PUTATIVE ASSOCIATION VIA COMMON ANTECEDENTS - FURTHER EVIDENCE FROM THE WHITEHALL STUDY [J].
JARRETT, RJ ;
SHIPLEY, MJ .
DIABETOLOGIA, 1988, 31 (10) :737-740
[65]   Lipoproteins and diabetic microvascular complications [J].
Jenkins, AJ ;
Rowley, KG ;
Lyons, TJ ;
Best, JD ;
Hill, MA ;
Klein, RL .
CURRENT PHARMACEUTICAL DESIGN, 2004, 10 (27) :3395-3418
[66]  
Jilma B, 1996, THROMB HAEMOSTASIS, V76, P328
[67]   Plasminogen activator inhibitor-1, inflammation, obesity, insulin resistance and vascular risk [J].
Juhan-Vague, I ;
Alessi, MC ;
Mavri, A ;
Morange, PE .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2003, 1 (07) :1575-1579
[68]  
JUHANVAGUE I, 1989, THROMB HAEMOSTASIS, V61, P370
[69]   Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris [J].
JuhanVague, I ;
Pyke, SDM ;
Alessi, MC ;
Jespersen, J ;
Haverkate, F ;
Thompson, SG .
CIRCULATION, 1996, 94 (09) :2057-2063
[70]   INVOLVEMENT OF THE HEMOSTATIC SYSTEM IN THE INSULIN-RESISTANCE SYNDROME - A STUDY OF 1500 PATIENTS WITH ANGINA-PECTORIS [J].
JUHANVAGUE, I ;
THOMPSON, SG ;
JESPERSEN, J .
ARTERIOSCLEROSIS AND THROMBOSIS, 1993, 13 (12) :1865-1873